Published in Gut on February 01, 1988
Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci (1997) 1.99
Oesophageal motor function before and after healing of oesophagitis. Gut (1992) 1.13
Histamine-2-receptor antagonists in gastro-oesophageal reflux. Gut (1989) 1.09
Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia. Gut (1993) 0.78
Comparison of esophageal motility in patients with solid dysphagia and mixed dysphagia. Dysphagia (2005) 0.77
Healing of severe esophagitis improves esophageal peristaltic dysfunction. Dig Dis Sci (1999) 0.77
Manometric study of hiatal hernia and its correlation with esophageal peristalsis. Dig Dis Sci (1999) 0.76
Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med (1982) 5.07
Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21
Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07
Effect of dry swallows and wet swallows of different volumes on esophageal peristalsis. J Appl Physiol (1975) 1.42
Experimental esophagitis in cats impairs lower esophageal sphincter pressure. Gastroenterology (1975) 1.38
A comparison between primary esophageal peristalsis following wet and dry swallows. J Appl Physiol (1973) 1.37
Motor activity of the distal oesophagus and gastrooesophageal reflux. Gut (1984) 1.35
Does surgery correct esophageal motor dysfunction in gastroesophageal reflux. Ann Surg (1981) 1.22
When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment. Dig Dis Sci (1982) 1.20
Clinical and manometric findings in benign peptic strictures of the esophagus. Dig Dis Sci (1979) 1.11
Studies on the mechanism of esophagitis-induced lower esophageal sphincter hypotension in cats. Gastroenterology (1976) 0.93
Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus. Gut (1981) 0.85
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34
Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med (1996) 3.47
Persistent hepatitis C viraemia without liver disease. Lancet (1993) 3.14
Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med (1997) 2.33
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci (1989) 2.17
Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig Liver Dis (2001) 1.99
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab (1993) 1.94
Enzymatic determination of cholesterol in bile. Clin Chim Acta (1975) 1.88
Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology (1991) 1.82
Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology (1989) 1.81
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology (1992) 1.72
Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology (1989) 1.70
Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett Appl Microbiol (2000) 1.70
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol (1994) 1.69
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther (1994) 1.59
High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther (2003) 1.57
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology (1994) 1.53
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
Lipid peroxidation and antioxidant status in adults receiving lipid-based home parenteral nutrition. Am J Clin Nutr (1998) 1.47
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme. Dig Liver Dis (2002) 1.42
Diabetic retinopathy in chronic pancreatitis. Gastroenterology (1990) 1.41
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. Hum Pathol (2004) 1.39
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Lipid, lipoprotein, and apolipoprotein assessment during an 8-wk very-low-calorie diet. Am J Clin Nutr (1992) 1.37
Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology (1997) 1.36
Assessment of portal hypertension by endoscopic ultrasonography. Gastrointest Endosc (1990) 1.34
Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment Pharmacol Ther (2003) 1.33
Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci (1989) 1.30
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab (1989) 1.29
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci (1999) 1.29
The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid. Digestion (1976) 1.29
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology (2000) 1.21
Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology (1991) 1.20
The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther (2002) 1.20
Review article:invasive and non-invasive tests for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.19
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci (1995) 1.17
Diagnostic value of serum primary bile acids in detecting bile acid malabsorption. Gut (1982) 1.16
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy (1992) 1.12
Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci (1981) 1.11
Function of the internal anal sphincter and rectal sensitivity in idiopathic constipation. Digestion (1982) 1.10
Endoscopic ultrasonography in the diagnosis of gastric submucosal tumor. Gastrointest Endosc (1989) 1.10
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut (1997) 1.09
Enterohepatic circulation of bile acids after cholecystectomy. Gut (1978) 1.08
Review article: diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther (2002) 1.07
Bile acid malabsorption and bile acid diarrhea in intestinal resection. Dig Dis Sci (1982) 1.06
Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss. Ann Nutr Metab (1989) 1.06
Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci (1994) 1.05
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases. Aliment Pharmacol Ther (1993) 1.03
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci (1997) 1.03
Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection. JPEN J Parenter Enteral Nutr (1994) 1.03
Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res (1990) 1.02
New immunological assays for the diagnosis of Helicobacter pylori infection. Gut (1999) 1.02
Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology (1991) 1.02
Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. J Med Virol (1991) 1.02
Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol (1992) 1.02
Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology (1988) 1.02
Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. Scand J Gastroenterol (1992) 1.01
Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology (1983) 1.00
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment. Aliment Pharmacol Ther (2003) 1.00
A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests. Am J Gastroenterol (1984) 1.00
Anti-CagA reactivity in Helicobacter pylori-negative subjects: a comparison of three different methods. Dig Dis Sci (1999) 0.97
For a cultural change in drug prescriptions in gastroenterology. Ital J Gastroenterol Hepatol (1998) 0.97
Diagnostic accuracy of a new rapid urease test (Pronto Dry), before and after treatment of Helicobacter pylori infection. Minerva Gastroenterol Dietol (2005) 0.97
Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel. Cancer (1991) 0.97
Treatment of pancreatic pseudocysts with octreotide. Lancet (1991) 0.96
Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol (1988) 0.96
Serum bile acids in newborns and children. Pediatr Res (1980) 0.96
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients. J Clin Pathol (1993) 0.95
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation. Dig Dis Sci (1991) 0.95
Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. Hepatology (1992) 0.95